Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840694 · ClinicalTrials.gov registry record · NA
Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03840694 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 21 participants.
The verdict
NCT03840694, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study is designed to find out how smoking affects the way the brain responds to pleasure and how this impacts smokers' behavior. Participants will complete three sessions. The first session will be a screening and training visit to determine final eligibility. Eligible participants will work with a researcher to develop brief scripts about times when they smoke and do other activities. Next, participants will attend two magnetic resonance imaging (MRI) scans - one after abstaining from smoking for 24 hours and the other after smoking as usual. After the second MRI, participants will answer questions on their phone every day for two weeks.
Interventions
- OTHER Smoking Abstinence
- OTHER Ad Lib Smoking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-09-10 |
| Est. Completion | 2021-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03840694
The ClinicalTrials.gov registry entry for NCT03840694 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smoking Abstinence is the first listed.
NCT03840694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03840694 about?
NCT03840694 is a clinical study titled "Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior". This study is designed to find out how smoking affects the way the brain responds to pleasure and how this impacts smokers' behavior. Participants will complete three sessions. The first session will be a screening and training visit to determine final eligibility. Eligible participants will work wi...
What is the current status of trial NCT03840694?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2019-09-10. Estimated completion is 2021-05-13.
What interventions are being tested in trial NCT03840694?
The interventions under investigation include: Smoking Abstinence (OTHER), Ad Lib Smoking (OTHER).
Who is sponsoring clinical trial NCT03840694?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.